Nolan, T. Et Al. 2024. 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.. Open forum infectious diseases , vol.11, no.11 .

Nolan, T., Bhusal, C., Beran, J., Bloch, M., Cetin, B. S., Dinleyici, E. C., ... Dražan, D.(2024). 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.. Open forum infectious diseases , vol.11, no.11.

Nolan, Terry Et Al. "4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.," Open forum infectious diseases , vol.11, no.11, 2024

Nolan, Terry Et Al. "4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.." Open forum infectious diseases , vol.11, no.11, 2024

Nolan, T. Et Al. (2024) . "4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.." Open forum infectious diseases , vol.11, no.11.

@article{article, author={Terry Nolan Et Al. }, title={4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults.}, journal={Open forum infectious diseases}, year=2024}